Skip to main content
. 2021 Jul 20;12:699044. doi: 10.3389/fphar.2021.699044

TABLE 4.

Preclinical studies showing therapeutic phytochemicals/herbal derivatives against tobacco/alcohol-associated HNC.

Bioactive compound/ Herbal derivative Cell type/Model Test and oosage Anti-tumour outcome Molecular outcome References
PubChem CID (Class)
Source
Curcumin In vitro: MDA 1986 (OSCC), Tu 686 (LSCC), Tu 167, JMAR C42 (Floor of mouth OSCC), MDA 686LN (OPSCC) Cell proliferation: 10 μM, 50 μM • Proliferation↓ • NF-κB activation↓ Aggarwal et al. (2004)
 CID- 969516 • Apoptosis↑ • Bcl-2↓, cyclin D1↓, IL-6↓, COX-2↓, MMP-9↓
 (Phenolics) • Arrests cell cycle in G1/S phase
Curcuma Longa
Gossypol In vitro: UMSCC-1, UMSCC-17B (Floor of mouth OSCC), Human oral keratinocytes and Normal keratinocytes Cell proliferation: • Proliferation↓ NA Wolter et al. (2006)
 CID- 3503 UMSCC-1, UMSCC-17B, Human oral keratinocytes and Normal keratinocytes IC50- 3, 6,2, 12.5 μM respectively • Growth of tumour↓
 Phenolic • Mitotic rate↓
Gossypium arboreum L. In vivo: NCr-nu/nu mice • Apoptosis↑
Berberine In vitro: HSC-3 (Tongue OSCC) Cell viability: • Cell viability↓ • Bcl-2↓, BAX↑, p53↑ Lin et al. (2007)
 CID: 2353 10 μM • G0/G1-phase arrest • Cyt C release
 (Alkaloid) • ROS↑,Ca2+↑, MMP↓, Apoptosis↑
Rhizoma coptidis
In-vitro study: FADU (Hypopharyngeal SCC) Cell cytotoxicity: • Cytotoxicity ↑ • FasL ↑, TRAIL ↑ Seo et al. (2015)
• Cleaved caspase-8 ↑, cleaved
12 or 25 μM for 24 h • Apoptosis ↑ • caspase-7 ↑
• Cell viability ↓ • Bcl-2 ↓, Bcl-xL ↓, Bax ↑, Bad ↑, Apaf-1↑, cleaved caspase-9 ↑, cleaved caspase-3 ↑, PARP ↑
• Cell migration ↓
• MMP-2 ↓, MMP-9 ↓
• ERK, JNK and p38 phosphorylation ↓
Physalis angulate In-vitro study: HSC-3 (OSCC) Cell viability: • Mitochondrial reductase activity ↓ • ROS ↑ Lee et al. (2009)
• Apoptosis ↑ • Bcl2 ↓, Bax ↓, AIF ↓, cytochrome c ↓, proform caspase-3 protein levels ↓, caspase-9 ↑, proform caspace-4 protein levels ↑, MMP attenuated
 (Crude extract) IC50: 10 μg/ml • Oxidative stress ↑
• Loss of cell function ↑
• ORP150 ↓, HSP70 ↑
• S- and G2/M-phase arrest • HO-1 ↑, SOD ↑
• Mitochondrial function impaired
Guggulsterone In vitro: SCC-4 (Tongue OSCC), HSC-2 (OSCC) Protein expression: NA • Phosphorylation of p65, IkBα & STAT3, NF-κB↓
 CID- 6450278 50 μM
 (3-hydroxy steroid) • IL-6↓ , COX-2↓
Commiphora mukul • Expression VEGF↓
Proanthocyanidins In vitro: UMSCC-1, UMSCC-5 (Floor of mouth OSCC), FaDu (Hypopharyngeal OSCC), OSC-19 (Tongue OSCC), Beas-2B (Bronchial Epithelium transformed with Ad12-SV40 2B) In vitro: IC50- 101 nM, 67 nM for • Cell viability↓ • Cyclin D1↓ and Cyclin D2↓ Prasad and Katiyar, (2012)
 CID- 108065 24 and 48 hrs, respectively • Apoptosis↑ • cdk2↓, cdk4↓, cdk6↓
• G1 phase arrest • Cip1/p21↑ and Kip1/p27↑
In vivo: 0.5%, w/w • 61% less tumor volume (p<0.001) • Bax↑, Bcl-2↓, caspase 3↑ and poly(ADP-ribose)polymerase↑.
 (Phenolic)
Vitis vinifera
In vivo: athymic nude mice
Wogonin In vitro: NPC-TW076, NPCTW039 (NPSCC) Autophagy: 50 μM • Autophagy↑ • P13K/Akt↓, mTOR/P70S6K↓, c-Raf/ERK↓ Chow et al. (2012)
 CID- 5281703 • Apoptosis↑
 (Phenolic)
Scutellaria baicalensis
Caffeic Acid Phenethyl Ester In vitro: TW2.6 (OSCC) Cell proliferation: IC50- 83.8, 46.6, and 18.8 μM for 24, 48, and 96 h treatment, respectively • Cell proliferation↓, colony formation↓ • Akt↓, GSK3β↓, FOXO1↓, FOXO3a↓, NF-κB↓, Rb↓, Skp2↓, cyclin D1↓, p27Kip↑ Kuo et al. (2013)
 CID- 5281703 • Apoptosis↑
 (Phenolic) • G1 phase↓, G2/M phase↑ cell population
Populus nigra L.
Ellagic acid In vitro: HSC-2 (OSCC), HF-1 (Normal fibroblasts) Cytotoxicity: (IC50- 260 & 142 μM on 2nd and 3rd day of exposure, respectively) • Apoptosis↑ • Caspase 3/7 ↑ Weisburg et al. (2013)
 CID- 5281855 • Cleavage of poly ADP ribose polymerase
 (Phenolic)
Rubus occidentalis
Cucurbitacin In vitro: Cytotoxicity: IC50- 3.7 μM • Sub G0/G1 phase arrest • Caspase 3 Activation Hung et al. (2013)
 CID- 5281316 SAS (Tongue OSCC) • Apoptosis↑ • MMP↓
 (Terpene)
Cucumic melo L
BME In vitro: Cal-27 (Tongue OSCC), JHU-22, JHU-29 (Laryngeal SCC) In vitro: 1% BME • Cell proliferation↓ • c-Met signaling pathway↓ Rajamoorthi et al. (2013)
 (crude extract) In vivo: 100 μl BME (0.1 g/ml) for 5 days • Tumor growth and volume↓ • Mcl-1, pSTAT3, cMyc expression↓
Momordica charantia • Keratinocyte formation↓, mitosis↓ • cyclinD1↓, survivin↓, cell arrest
In vivo: BALB/c athymic nude mice • MCM2↓
Honokiol In vitro: SCC-1, SCC- 5 (Floor of mouth OSCC), OSC-19 (Tongue OSCC), FaDu (Hypopharyngeal SCC) In vitro: ∼60 μM for 24, 48 and 72 hrs • Cell viability↓ • Expression levels of Cyclins: D1, D2, and Cdks: 4 and 6↓ Singh et al. (2015)
 CID-72303 • Apoptosis↑
 (Phenolic) In vivo: 100 mg/kg body weight (mw-266.3) • EGFR↓, mTOR and their downstream signalling molecules↓
Magnolia officinalis
Cepharanthine In vitro: CNE-1, CNE-2 (NPSCC) Cell proliferation: • Cell proliferation↓ • DNA repair genes ↓ Liu et al. (2015)
 CID- 10206 IC50 for CNE-1 and CNE-2: 20 and 32 nM after 48 hrs, respectively • G1 phase arrest
 (Alkaloid)
Stephania cepharantha
MEAG In vitro: MC3 (Chronic myelogenous leukemia), HN22 (OSCC) Cytotoxic effect: • Mitochondria mediated apoptosis↑ • MMP↓, Cyt C release, caspase 9 ↑, t-Bid↑, cleaved caspase-8↑, DR5↑. Lee et al. (2016)
 (Crude extract) IC50 for MC3 and HN22: 6.5 and 4.6 μg/ml, respectively
 (Terpenes) • Nuclear condensation and fragmentation
Withania somnifera
Goniothalamin In vitro: H400 (OSCC) Cytotoxic effect: • Cell viability↓ • MMP↓, Cyt C release Li et al. (2016)
 CID- 6440856 IC50: 8.9 nM after 72 h • Cell proliferation↓ • NF-κB activation↓
 (Phenolic) • Apoptotic-like morphology (cell shrinkage, dense cytoplasm, blebbing of cell surface)
Goniothalamus marcrophyllus
• S phase arrest.
Lupeol In vitro: Cell viability: • G1 phase arrest • Expression p53↑, Bax↑, CDKN2A↑, CyclinD1↓, Ki67↓ Bhattacharyya et al. (2017)
 CID- 259846 HEp-2 (Human papillomavirus-related endocervical adenocarcinoma), UPCI:SCC131 (Floor OSCC) IC50 for Hep-2 and SCC131: 53.5 and 52.4 μM after 24 hrs, respectively • Apoptosis↑ via intrinsic pathway
 (Terpene) • Cell viability↓ • Caspase 3 activation
Camellia japonica
Ex vivo: Fresh HNSCC tumor tissues
Icaritin In vitro: KB (Human papillomavirus-related endocervical adenocarcinoma), SCC9 (Tongue OSCC) Cell viability: • Mitochondria mediated apoptosis↑ • MMP↓, Cyt c release Jin et al. (2017)
CID- 5318980 ∼20 μM for 24 and 48 h • miR-124↑
(Phenolic) • Sp1/DNMT1 signaling↓
Epimedium grandiflorum
Osmuda regalis root In vitro: FaDu (Hypopharyngeal SCC), HLaC78, HLaC79, HLaC79-tax (LSCC) Cytotoxicity: • Cell growth↓ • CLEC3B↓, KAL1↓, MMP 11↓, MMP 15↓, MMP2↓ Schmidt et al. (2017)
 (crude extract) IC50 for HLaC79, FaDu, HLaC79-Tax and HLaC79: 21.4, 8.5, 20.6 and 9.9 μg/ml, respectively • Apoptosis↑
Osmuda regalis • Invasion↓ • Integrin such as ITGB3↑, ITGA1↑, ITGAM↑
• metastasis genes such as CTFG↑, PPIA↑, SELP↑, VCAN↑
Piperine In vitro: KB (Human papillomavirus-related endocervical adenocarcinoma) Cell proliferation: • Apoptosis↑ • ROS↑, MMP↓ Siddiqui et al. (2017)
 CID- 638024 IC50: 124 μM for 24 h • Cell viability↓ • Caspase 3 activation
 (Alkaloid) • Cell growth↓
Piper nigrum • Cellular morphological changes
• G2/M phase arrest
Embelin In vitro: SCC25, Cas9-22, YD10B (Tongue squamous cell carcinoma) Cytotoxicity: • Cell viability↓ • MMP↓, caspase 9 & 3↓ Lee et al. (2017)
0–300 μM for 24 h; cell specific effect • Condensed fragmented nuclei • p62/SQSTM1↓
• Autophagic vacuoles appears • Conversion↑ LC3-I to LC3-II
 CID- 32798
 (Phenolic)
Embelia ribes
Dihydroartemisinin In vitro: Cal-27 (Tongue OSCC) Cell proliferation: • Autophagosomes↑ • LC3-II ↑, Bevlin-1↑, γH2AX foci↑ Shi et al. (2017)
 CID- 3000518 IC50: 24.4 μM for 24 h • Oxidative stress↑ • STAT3 activation↓ and disrupted p-STAT3 nuclear translocation
• DNA double-strand break
 (Sesquiterpene lactone) • Weight and volume of Xenograft tumor↓ by 56.58%
Artemisia annua
β-Elemene In vitro: YD-38 (Gingival OSCC) Colony formation and Apoptosis: • Cell proliferation↓ • Expressions of STAT3↓, p-STAT3↓, p-JAK2↓, and Bcl-2↓, Bax↑ and caspase-3↑ Huang and Yu, (2017)
 CID- 6918391 In vivo: BALB/c nude mice • Apoptosis↑
 (Terpene) 195 nM β-Elemene
Curcuma wenyujin • Block JAK2-STAT3 pathway
Thymol In vitro: Cal27, SCC-4, SCC-9 (Tongue OSCC) Cytotoxicity: • Cell viability↓ • c-PARP↑, MMP dysfunction De La Chapa et al. (2018)
 CID- 6989 In vivo: Athymic nu/nu mice 2.3 µM • No colony formation
 (Terpene) In vivo tumor growth↓
Thymus vulgaris • Apoptosis↑
Tanshinone In vitro: SCC-9 (Tongue OSCC) Cell viability: • Apoptosis↑ • LC3-I↑ Qiu et al. (2018)
 CID- 114917 In vivo: BALB/c-nu IC50: 17.5 μM. • Autophagy↑ • Beclin-1/Atg7/Atg12-Atg5 pathway↑
 (Abietane diterpenoid) • Growth of solid tumors in vivo • PI3K/Akt/mTOR pathway↓
Salvia miltiorrhiza
Oridonin In vitro: UM1, SCC25 (Tongue OSCC) Cell proliferation: • G2/M phase arrest • Bax/Bcl-2↑ Yang et al. (2018b)
 CID- 5321010 IC50 for SCC25, UM1, UM2, HSC3 and Ca127: 9.1, 8.2, 10.6, 15.4 and 9.6 μM, respectively. • Apoptosis↑ • Cyclin B1↓, pCDK1↑, cyclin D1↑, cyclin D3↑, p21↑ and cyclin A2↑
 (Terpene)
Rabdosia rubescens • Activates caspase-3, caspase-9 and PARP-1
• P13K/Akt/mTOR pathway↓
Epigallocatechin-3-gallate In vitro: HSC (Tongue OSCC) Cell proliferation: • Cell viability↓ • Caspase‑3 and -7↑ Yoshimura et al. (2019)
In vivo: BALB/c nude (nu/nu) mice IC50 value at 24, 48 and 72 h were >100, 43.2 and 39.3 μM, respectively • G1 phase arrest • miR-22↑
 CID- 65064 • Apoptosis↑
 (Phenolic) • Tumor size↓ 45.2%
Camellia sinensis
Quercetin In vitro: hNOK (Human normal oral keratinocytes), Tc8113, SAS (Tongue OSCC) Cell viability: • Cell viability↓ • miR-22/WNT1/Beta-catenin pathway↓ Zhang et al. (2019)
 (Phenolic) CC50 for hNOK, Tc8113 & SAS: 298.6, 48.7 & 44.3 mM, respectively • Tumor volume and weight↓
 CID: 5280343
Allium cepa L.
In vivo: BALB/c nu/nu mice
Ursolic Acid In vitro: Ca9-22 (Tongue OSCC), SCC2095 (OSCC) Cell proliferation: • Caspase-dependent apoptosis • Akt/mTOR/NF-κB signaling↓, ERK↓, and p38↓ Lin et al. (2019)
 CID- 64945 IC50 for UA, Ca9-22: 11.5 and 13.8 μM, respectively • Autophagy↑, autophagosomes↑
 (Terpene) • Migration↓, Invasion↓ • LC3B-II conversion, p62↑
Salvia rosmarinus • Proteolytic activity of MMP-2↓
Shikonin In vitro: 5-8F (NPSCC) Cell proliferation: • Necroptosis↑ • Necrostatin-1↑ Liu et al. (2019)
 CID- 479503 In vivo: BALB/c nude mice IC50: 7.5 μM after 6 h In vivo tumor growth↓ • RIPK1↑, RIPK3↑, MLKL↑
 (Hydroxy-1,4-naphthoquinone) • Caspase-8 and -3↑
• ROS↑
Lithospermum erythrorhizon
Chrysophanol In vitro: FaDu (Hypopharyngeal SCC), SAS (Tongue OSCC) Cell viability: • Cell viability↓ • ROS↑ Hsu et al. (2020)
 CID- 10208 IC50 for FaDu and SAS: 9.6 ± 1.3 and 12.6 ± 2.1 μm at 24 h, respectively • G1 phase arrest • Expression of procaspase 3↓, cyclin D1↓, CDK4↓, CDK2↓, cdc2↓
 (Phenolic) • Metastasis↓, EMT↓
Rheum rhabarbarum
Moscatilin In vitro: FaDu (Hypopharyngeal SCC) Cell cytotoxicity: • Cell viability↓ • Activation of caspases-3,-8,-9,-7↑ Lee et al. (2020)
 CID- 176096 IC50: 1.4 μM at 72 h • Cell proliferation↓ • MMP↓, Cyt C release
 (Phenolic) • Apoptosis via intrinsic as well as extrinsic pathway • JNK pathway↓
Dendrobium sp.
Demethoxycurcumin In vitro: Cell proliferation: • Cell viability↓ • cIAP1/XIAP↓, heme oxygenase-1↑ Chien et al. (2020)
SCC-9, HSC-3 (Tongue SCC) IC50: 50 μM • Cell proliferation↓ • Caspase-3↑, -9↑, -8↑, p38-MAPK-HO-1 signaling↑, MAPK↑, JNK1/2↑
 CID- 5469424 • G2/M phase arrest
 (Phenolic) • Morphological changes
Curcuma Longa

Abbreviations: Akt- Protein kinase B; Apaf-1- Apoptotic protease activating factor 1; Atg7- Autophagy related 7; Bad- BCL2-associated Agonist of cell Death; Bcl-2- B-cell lymphoma 2; BME- Bitter Melon Extract; Cdc2- Cell division control 2; Cdk2- Cyclin-dependent kinase 2; CDKN2A- Cyclin-dependent kinase inhibitor 2A; cIAP- Calf Intestinal Alkaline phosphatase; Cip1- CDK interacting protein 1; CLEC3B- C- type lectin domain family three member B; c-Met- tyrosine-protein kinase Met; COX-2- Cyclooxygenase-2; c-PARP- Cleaved Poly (ADP-ribose) polymerase; c-Raf-c- Rapidly Accelerated Fibrosarcoma; CTGF- Connective tissue growth factor; Cyt C- Cytochrome complex; DNMT1- DNA (cytosine-5)-methyltransferase 1; DR5- Death receptor five; ERK- Extracellular-signal-regulated kinase; FasL- Fast ligand or cell death receptor; FOXO1- Forkhead box protein O1; GSK3β- Glycogen synthase kinase three beta; H&N- Head and neck; HO-1- Heme oxygenase 1; HSP70–70 kilodalton heat shock proteins; IkBα- I-kappa-B-alpha; ITGA1- Integrin alpha-1; ITGAM- Integrin alpha M; ITGB3- Integrin beta three; JNK- c-Jun N-terminal kinase; Kip1- kinase inhibitor 1; LC3- Microtubule-associated protein 1A/1B-light chain three; MAPK- Mitogen-activated protein kinase; Mcl-1- Myeloid leukemia cell differentiation protein 1; MCM2- Minichromosome maintenance protein complex 2; MLKL- Mixed lineage kinase domain-like pseudokinase; MMP- Matrix metallopeptidase; mTOR-mammalian target of rapamycin; NF-κB- Nuclear factor kappa light chain enhancer of activated B cells; ORP150–150-kDa oxygen-regulated protein; P13K- Phosphatidylinositol 3-kinase; P70S6K- 70-kDa ribosomal protein S6 kinase; PARP- Poly-ADP ribose polymerase; JAK- Janus kinase; PPIA- Peptidylprolyl isomerase A; Rb- Retinoblastoma protein; RIPK1- Receptor-interacting serine/threonine-protein kinase 1; ROS- Reactive oxygen species; SOD- Superoxide dismutases; Sp1- Specificity protein 1; SQSTM1- Sequestosome-1; STAT3- Signal transducer and activator of transcription three; t-Bid-truncated BH3 interacting-domain death agonist; TRAIL- TNF-related apoptosis-inducing ligand; VEGF- Vascular endothelial growth factor; WNT1- Wingless-related integration site 1; XIAP- X-linked inhibitor of apoptosis protein; yH2AX- Phosphorylated X-linked inhibitor of apoptosis protein.